METSERA

HQ - New York

Summary

Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 233 M

Avg. Deal Size£ 233 M

Market Context

Senior Management